Strategic partnerships There is a history of collaborations with major biopharma players (Roche) and acquisition activity (Invitae) that signals openness to distribution and integration partnerships. Target potential DL partners or CROs and fertility clinics seeking expanded genetic screening offerings.

Clinical expansion Product suite covers preimplantation and carrier screening with scalable saliva-based options (VeriYou) and cost advantages. Explore partnerships with IVF clinics, fertility networks, and hospital systems seeking comprehensive, cost-efficient genetic testing for reproductive patients.

Customer care Emphasis on world-class customer care and genetic counseling presents a value proposition for clinics seeking high-touch support and patient education. Leverage training, counseling services, and patient resources to upsell bundled testing and ongoing genetic counseling plans.

Growth signals Revenue range aligns with mid-market genetic testing firms; funding raised indicates capacity for scale. Pursue channel sales with mid-sized fertility labs, regional hospital systems, and managed care networks aiming to expand reproductive genetics offerings.

Tech enablement Active tech stack including analytics, cloud services, and modern web frameworks suggests strong digital engagement capabilities. Propose integrated digital marketing, patient onboarding, and analytics-enabled decision support tools to clinics seeking streamlined operations and measurable outcomes.